Salbutamol in treatment of heart failure.

Salbutamol in treatment of heart failure.

The haemodynamic effects of oral and intravenous salbutamol were investigated in 22 patients with chronic heart failure. Intravenous salbutamol (13 micrograms/min) increased cardiac index by 53 per cent from 1.5 +/- 0.13 1/min per m2 to 2.3 +/- 0.23 1/min per m2 and decreased systemic vascular resistance by 28 per cent from 29.4 +/- 3.9 units to 21.2 +/- 2.5 units. Heart rate rose by 10 per cen...

The effect of self-management based discharge planning on treatment adherence in patients with heart failure

Background & Aim: Patients with heart failure experience some outcomes such as poor self-management, poor adherence to treatment and low quality of life. The aim of the current study was to evaluate the effect of self-management based discharge planning on treatment adherence in patients with heart failure. Methods & Materials: In this quasi-experimental research, 80 patients with heart failur...

Treatment of Congestive Heart failure

Heart failure is defined as the inability of the heart to supply sufficient blood flow to meet the needs of the body. The term “congestive heart failure” implies that the impaired blood flow is causing fluid retention in the lungs, legs, ankles or feet. Other common symptoms include shortness of breath when lying down or during exercise, fatigue and weakness, reduced exercise capacity, and rapi...

Pharmacological Treatment of Heart Failure

Optimal treatment of heart failure is important to reduce hospitalization and mortality. In according to recommendation for treatment from major guideline, most patients with HF should be routinely managed with a combination of 3 types of drugs: a diuretic, an ACEI or an ARB, and a beta blocker. The value of these drugs has been established by the results of numerous large-scale clinical trials...

Drug treatment of heart failure.